首页> 美国卫生研究院文献>Journal of Applied Clinical Medical Physics >Dosimetric evaluation of a novel high dose rate (HDR) intraluminal / interstitial brachytherapy applicator for gastrointestinal and bladder cancers
【2h】

Dosimetric evaluation of a novel high dose rate (HDR) intraluminal / interstitial brachytherapy applicator for gastrointestinal and bladder cancers

机译:新型高剂量率(HDR)腔内/间质近距离放射治疗器对胃肠道和膀胱癌的剂量学评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

High dose rate (HDR) brachytherapy is one of the accepted treatment modalities in gastro‐intestinal tract and bladder carcinomas. Considering the shortcoming of contact brachytherapy routinely used in gastrointestinal tract in treatment of big tumors or invasive method of bladder treatment, an intraluminal applicator with the capability of insertion into the tumor depth seems to be useful. This study presents some dosimetric evaluations to introduce this applicator to the clinical use. The radiation attenuation characteristics of the applicator were evaluated by means of two dosimetric methods including well‐type chamber and radiochromic film. The proposed 110 cm long applicator has a flexible structure made of stainless steel for easy passage through lumens and a needle tip to drill into big tumors. The 2 mm diameter of the applicator is thick enough for source transition, while easy passage through any narrow lumen such as endoscope or cystoscope working channel is ensured. Well‐chamber results showed an acceptably low attenuation of this steel springy applicator. Performing absolute dosimetry resulted in a correlation coefficient of R=0.9916(pvalue107) between standard interstitial applicator and the one proposed in this article. This study not only introduces a novel applicator with acceptable attenuation but also proves the response independency of the GAFCHROMIC EBT films to energy. By applying the dose response of the applicator in the treatment planning software, it can be used as a new intraluminal / interstitial applicator.PACS number: 87.53.Bn, 87.53.Jw, 29.40.Cs
机译:高剂量率(HDR)近距离放射治疗是胃肠道和膀胱癌的公认治疗方式之一。考虑到在大肿瘤的治疗中通常在胃肠道中使用接触式近距离放射疗法的缺点或膀胱的侵入性治疗方法,具有能够插入肿瘤深度的腔内涂药器似乎是有用的。这项研究提出了一些剂量学评估,以将该涂药器引入临床。辐射器的辐射衰减特性通过两种剂量法进行了评估,包括井型室和放射致变色膜。拟议中的110厘米长的涂药器具有一种由不锈钢制成的柔性结构,可轻松穿过内腔,并具有可刺入大肿瘤的针尖。涂药器的2毫米直径足够厚,足以进行放射源转换,同时确保容易通过任何狭窄的内腔,例如内窥镜或膀胱镜工作通道。良好的腔室结果表明,这种钢质弹性涂抹器的衰减较低。进行绝对剂量测定得出相关系数为 R = 0.9916 p - 10 - 7 。这项研究不仅介绍了一种具有可接受衰减的新型涂布器,而且证明了GAFCHROMIC EBT膜对能量的响应独立性。通过在治疗计划软件中应用涂药器的剂量响应,可以将其用作新的腔内/间质涂药器.PACS编号:87.53.Bn,87.53.Jw,29.40.Cs

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号